VIDRL

A test using conventional PCR, sequencing, and analysis to genotype drug resistance in HIV-1 proviral DNA focusing on protease, reverse transcriptase (RT), and integrase regions.

A supplemental confirmatory assay for HIV 1/2 detecting antibodies and antigens in various blood and fluid specimens.

A serology test using ECLIA method for detecting total antibodies against SARS CoV-2 Spike protein. Diagnostic testing is not performed; it is for clinical trial and research testing only.

A serology test using ECLIA method for detecting total antibodies against SARS CoV-2 NCP. Intended for clinical trial and research testing only, not for diagnostic use.

Enzyme immunoassay for IgG detection using blood and plasma specimens with a turnaround time of up to 7 days.

An immunoassay test using IgG & IgM EIA and NS1 Antigen EIA methods for blood and plasma specimens with a turnaround time of up to 5 days.

A real-time TaqMan PCR test targeting the measles virus nucleoprotein (N) gene for detection of measles virus RNA in various specimen types.

A collection of diagnostic tests using Conventional PCR, Real-time PCR, and EIA blocking assay methods for various specimen types including blood, tissue, and fluids.

A real time Taqman PCR test for detecting HSV-1, HSV-2, CMV, and VZV from various specimen types.

PCR assay available on request for generic and species specific diagnosis of malaria.

Serological assays for detecting viral capsid antigen IgG and IgM antibodies.

Measures the amount of HBV in blood to guide clinical decisions and monitor therapy response using Abbott Alinity m, Roche COBAS 6800, and Cepheid GeneXpert platforms.

Measures HCV RNA amount in blood to predict therapy response using Abbott Alinity m assay with a dynamic range of 12 – 100,000,000 IU/mL.

Qualitative detection of HCV RNA in blood using Abbott Alinity m and Roche 6800 platforms with detection limits of 12 and 15 IU/mL respectively.

A real-time PCR test for detecting Neisseria gonorrhoea from various specimen types including aspirate, biopsy, cerebrospinal fluid, fluid, nucleic acid extract, swab, tissue, and urine.

Determines HCV genotype and subtypes using Abbott RealTime HCV Genotype II assay, Versant HCV Genotype 2.0 LiPA II assay, or sequence analysis of the core genome region.

A multiplex PCR test for detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and internal control, used for diagnosing gonorrhoea infection.

A PCR-based test kit for detecting pathogens using real-time PCR technology.

In-house assay measuring HDV RNA in blood to determine infection and monitor therapy response, detecting all known genotypes.

A test using conventional PCR, sequencing, and analysis to genotype Cytomegalovirus for drug resistance.

A confirmatory PCR assay detecting the cryptic plasmid of Neisseria gonorrhoeae used to retest presumptive positives from the multiplex PCR assay.

Population-based sequencing to detect resistance associated substitutions (RAS) to NS5A inhibitors in HCV, which can reduce treatment efficacy.

Sequencing of HBV polymerase/reverse transcriptase region to determine genotype and drug resistance mutations, including vaccine and immune escape mutants.

A real-time PCR test for detecting Mycobacterium tuberculosis complex DNA in various specimen types including aspirate, biopsy, bone marrow, cerebrospinal fluid, and others.

Test method using Conventional PCR for various specimen types including aspirate, biopsy, blood, bone marrow, and more.

Serological enzyme immunoassays for detecting nuclear antigen IgG and viral capsid antigens IgG and IgM.

Test methods using EIA, immunochromatography, and fluorescence immunoassay for detection from urine specimens.

Chemiluminescent immunoassay for antigen or antibody detection using blood and plasma specimens with daily testing and a turnaround time of up to 3 days.

Diagnostic test for enterovirus (poliovirus) isolation by cell culture with confirmatory testing by RT-PCR from faeces, swab, or virus isolate specimens.

Automated molecular diagnostic platforms for viral load quantification using serum or blood specimens with a turnaround time of 6 days and a testing frequency of 3 times weekly.

Lateral flow assay for detection of cryptococcal antigen in blood and cerebrospinal fluid with same day or next day turnaround time.

A diagnostic test available on request for the diagnosis of malaria.

A test using conventional PCR, sequencing, and analysis to genotype HIV-2 drug resistance in protease and reverse transcriptase regions.

Immunofluorescence test detecting total antibody to Legionella pneumophila serotype 1 and Legionella longbeachae.

Immunofluorescence test for IgM antibodies using blood and plasma specimens with a turnaround time of up to 7 days.

Chemiluminescent immunoassay for total antibody detection using blood and plasma specimens with a turnaround time of up to 3 days.

An IgG EIA test for detecting Chlamydia Group Antigen using blood, plasma, or serum specimens.

Immunofluorescence test for IgG antibodies using blood and plasma specimens with a turnaround time of up to 7 days.

The QuantiFERON ® -TB Gold assay detects CMI responses in-vitro to tuberculosis infection by measuring interferon-gamma (IFN-G) harvested in plasma from whole blood incubated with M. tuberculosis-specific antigens ESAT-6 & CFP-10. It is used as an alternative to the Mantoux test to detect latent TB infection, especially in patients vaccinated with BCG or when Mantoux test is contraindicated.

A test method combining microscopy and culture for specimens including cerebrospinal fluid, fluid, lavage, nail clippings, scraping, sputum, tissue, and washings, with a turnaround time of up to 5 weeks, Medicare rebateable.

Microscopy test method using stained thick and thin films from blood (EDTA), slide, or smear specimens, with same day or next day turnaround time.

Microscopy test method for faeces specimens to detect faecal parasites, with a turnaround time of 3-5 days, Medicare rebateable.

A test method using colourmetric microdilution based on CLSI M27A guidelines for culture isolates, with a turnaround time of 72 hours, non-rebatable.